Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-193963 ) of Revance Therapeutics, Inc. of our report dated March 28, 2014 relating to the financial statements which appear in this Form 10-K.

/s/ PricewaterhouseCoopers LLP

San Jose, CA

March 28, 2014